Lv7
4518 积分 2021-08-05 加入
Efficacy and safety of voclosporin versus placebo for lupus nephritis (AURORA 1): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial
1天前
已完结
All-cause, cause-specific and age-specific standardised mortality ratios of patients with systemic lupus erythematosus in Ontario, Canada over 43 years (1971–2013)
1天前
已完结
Mortality in patients with systemic lupus erythematosus: A meta-analysis of overall and cause-specific effects
1天前
已完结
Type I interferon inhibitor anifrolumab in active systemic lupus erythematosus (TULIP-1): a randomised, controlled, phase 3 trial
1天前
已完结
Systemic lupus erythematosus and risk of infection
2天前
已完结
Performance of the 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus in a multiethnic Malaysian cohort
3天前
已完结
Interaction between sleep quality and dietary inflammation on frailty: NHANES 2005–2008
3天前
已完结
Sleep and Inflammation
3天前
已完结
Inebilizumab for the treatment of neuromyelitis optica spectrum disorder (N-MOmentum): a double-blind, randomised placebo-controlled phase 2/3 trial
9天前
已完结
Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial
10天前
已完结
皖公网安备34019202002308
